Facebook is anticipated to have one of the of the most electrifying IPOs in technology company history. The company is hoping to have a valuation of over $100 billion when they go public and would raise as much as $10 billion or more. Facebook is believed to be targeting their IPO at between April and June 2012.

Facebook has announced that the company is moving from their current space in Palo Alto, CA to Sun Microsystem’s old 1 million square foot campus in Menlo Park, CA. The campus is located on the Bayfront Expressway and it has 11 buildings across 57 acres.

In late March, Facebook’s former CFO Gideon Yu had quit.  The rumor about why Yu left was that he was not getting along with Facebook co-founder Mark Zuckerberg.  An internal memo went around that Facebook was looking for a CFO that has more experience with a public company.

This is where former Genentech CFO David Ebersman comes in.  Genetech is a biotech company that was bought out by Swiss company Hoffman-La Roche for $46.8 billion on March 26, 2009.  Genentech is also an investor in 23andMe, a genetics company that was started by Google co-founder Sergey Brin’s wife.  Ebersman worked at Genentech for 15 years, but Hoffman already had a CFO making his job much less important.

Below is the full press release from Facebook that AllThingsD was able to get their hands on: